Leopold Balleisen

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

T. Brümmendorf, K. Spiekermann, M. Pfreundschuh, 2017, Leukemia.

Risk-adapted, treosulfan-based therapy with auto- and allo-SCT for relapsed/refractory aggressive NHL: a prospective phase-II trial

A. Ganser, G. Behre, A. Hinke, 2014, Bone Marrow Transplantation.

Age, not therapy intensity, determines outcomes of adults with acute myeloid leukemia

C Haferlach, W Hiddemann, T Haferlach, 2016, Leukemia.

Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia

E. Thiel, W. Hiddemann, T. Haferlach, 2016, Leukemia.